Filing Details
- Accession Number:
- 0001209191-19-024496
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-12 17:14:25
- Reporting Period:
- 2019-04-01
- Accepted Time:
- 2019-04-12 17:14:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1695580 | Kenneth Krogulski | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-04-01 | 382 | $5.99 | 156,682 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-02 | 580 | $6.12 | 157,262 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-03 | 80 | $6.00 | 157,342 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-04 | 241 | $6.19 | 157,583 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-05 | 183 | $6.32 | 157,766 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-08 | 65 | $5.98 | 157,831 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-09 | 65 | $6.40 | 157,896 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.